SEC 13F Intelligence

Boxer Capital, LLC / IMVT

Boxer Capital, LLC’s Immunovant Inc Position

Does Boxer Capital, LLC own Immunovant Inc (IMVT)? Not currently — the last reported position was 825.0K shares worth $24M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$24M
Q3 2024
Shares
825.0K
% of Portfolio
+1.15%
Quarters Held
7
position exited

Position History IMVT

Reported value by quarter
Q1 ’21: $16MQ1 ’21Q2 ’21: $11MQ2 ’21Q3 ’23: $29MQ3 ’23Q4 ’23: $42MQ4 ’23Q1 ’24: $27MQ1 ’24Q2 ’24: $22MQ2 ’24Q3 ’24: $24MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024825.0K$24M+1.15%
Q2 2024825.0K$22M+1.15%
Q1 2024825.0K$27M+1.32%
Q4 20231.00M$42M+2.10%
Q3 2023750.0K$29M+1.53%
Q2 20211.00M$11M+0.37%
Q1 20211.00M$16M+0.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of IMVT.